GSE131649 2 V 7 HEMIN HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE131649 2 V 7 HEMIN HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE131649 2 V 7 HEMIN HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE131649 2 V 7 HEMIN HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE131649 2 V 7 HEMIN HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

G protein signaling modulator 3

Gene

P2Y receptor family member 8

Gene

small integral membrane protein 38

Gene

PEDS1-UBE2V1 readthrough

Gene

small proline rich protein 2D

Gene

leucine rich repeat and coiled-coil centrosomal protein 1

Gene

synaptogyrin 1

Gene

transmembrane p24 trafficking protein 7

Gene

shiftless antiviral inhibitor of ribosomal frameshifting

Gene

calcium channel flower domain containing 1

  • Gene

    G protein signaling modulator 3


  • Gene

    P2Y receptor family member 8


  • Gene

    small integral membrane protein 38


  • Gene

    PEDS1-UBE2V1 readthrough


  • Gene

    small proline rich protein 2D


  • Gene

    leucine rich repeat and coiled-coil centrosomal protein 1



  • Gene

    transmembrane p24 trafficking protein 7


  • Gene

    shiftless antiviral inhibitor of ribosomal frameshifting


  • Gene

    calcium channel flower domain containing 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.